Evaluating dietary supplements and exercise for patients with sarcopenia and lung disease
Evaluate the Effect of Dietary Supplement Combined Supervised Exercise on Physical Performance and Body Composition Among Patients With Sarcopenia and Severe Sarcopenia Comorbid With COPD or ILD: A Prospective, Multi-center Cohort Study
This study is testing whether a combination of dietary supplements and supervised exercise can help people with sarcopenia and lung diseases like COPD and ILD improve their physical performance and lung function.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 100 (estimated) |
| Sex | All |
| Sponsor | Orient Europharma Co., Ltd. Industry-sponsored |
| Locations | 1 site (Taichung) |
| Trial ID | NCT05926713 on ClinicalTrials.gov |
What this trial studies
This clinical trial is a prospective, multi-center study aimed at assessing the effects of dietary supplements combined with supervised exercise on physical performance, body composition, and lung function in patients suffering from sarcopenia associated with chronic lung diseases such as COPD and ILD. Participants will undergo a 12-week intervention, after which their improvements will be analyzed to provide insights into effective clinical interventions for rehabilitation. The study will also track participants for an additional year to evaluate long-term benefits of the nutritional supplements provided.
Who should consider this trial
Good fit: Ideal candidates include outpatients diagnosed with COPD or ILD who also meet the criteria for sarcopenia.
Not a fit: Patients who are bedridden, under 20 years old, or have terminal illnesses may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could enhance physical performance and lung function in patients with sarcopenia and chronic lung disease.
How similar studies have performed: Other studies have shown promising results with similar interventions combining exercise and nutritional support for sarcopenia, indicating potential for success in this approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Outpatients with COPD (chronic obstructive pulmonary disease) or ILD (interstitial lung disease) from Department of Chest medicine in Taichung Veterans General Hospital, judged by the doctor that they do not need hospitalization or emergent treatment. * Outpatients who meet the diagnostic criteria for Sarcopenia after evaluation by a physician. Exclusion Criteria: * Patients who refuse to sign the consent form * Patients who are under 20 years old * Patients who are bedridden or unable to walk due to physical disabilities * Patients with terminal cancer or human-acquired immunodeficiency syndrome * Patients with edema (grading pitting edema +2)
Where this trial is running
Taichung
- Taichung Veterans General Hospital — Taichung, Taiwan (Recruiting)
Study contacts
- Principal investigator: Pin-Kuei Fu — Department of Chest Medicine of Taichung Veterans General
- Study coordinator: Pin-Kuei Fu, PhD
- Email: yetquen@vghtc.gov.tw
- Phone: 04-23592525
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.